Yaguang Zhang Selected Research

Yaguang Zhang Research Topics

Disease

17	Neoplasms (Cancer) 04/2024 - 01/2016
6	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2017
6	Inflammation (Inflammations) 12/2023 - 10/2020
4	Pneumonia (Pneumonitis) 12/2023 - 01/2022
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 03/2022
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 11/2019
3	Asthma (Bronchial Asthma) 12/2023 - 01/2022
2	Carcinogenesis 03/2024 - 10/2014
2	Infections 08/2023 - 01/2021
2	Hyperglycemia 09/2022 - 10/2020
2	COVID-19 10/2021 - 01/2020
1	Mulibrey Nanism (Mulibrey Nanism Syndrome) 08/2023
1	Genomic Instability 03/2023
1	Hypersensitivity (Allergy) 01/2023
1	Respiratory Syncytial Virus Infections 01/2023
1	Wolf-Hirschhorn Syndrome 01/2023
1	Liver Diseases (Liver Disease) 10/2022
1	Diabetes Mellitus 09/2022
1	Proteinuria 09/2022
1	Graves Ophthalmopathy 01/2022
1	Hyperthyroidism 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Chronic Hepatitis C 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2020
1	Glucose Intolerance 10/2020
1	Insulin Resistance 10/2020
1	Breast Neoplasms (Breast Cancer) 06/2018

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2014
4	Peptides (Polypeptides)IBA 03/2019 - 01/2016
3	RNA (Ribonucleic Acid)IBA 03/2024 - 11/2022
3	EnzymesIBA 01/2023 - 01/2017
3	Small Interfering RNA (siRNA)IBA 03/2022 - 10/2014
3	PolyethyleneimineIBA 03/2019 - 01/2016
2	AntibodiesIBA 08/2023 - 10/2021
2	Histones (Histone)IBA 03/2023 - 01/2023
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 01/2022
2	Interleukin-33IBA 01/2023 - 01/2022
2	Peptide Initiation Factors (Initiation Factor)IBA 11/2022 - 10/2014
1	GalactosidasesIBA 04/2024
1	Transfer RNA (tRNA)IBA 03/2024
1	CilengitideIBA 01/2024
1	Extracellular Matrix ProteinsIBA 01/2024
1	Sorafenib (BAY 43-9006)FDA Link 01/2024
1	ferrostatin-1IBA 01/2024
1	salvianolic acid BIBA 01/2024
1	Melanocyte-Stimulating Hormones (MSH)IBA 12/2023
1	CXCR4 Receptors (CXCR4 Receptor)IBA 04/2023
1	Nucleosomes (Nucleosome)IBA 03/2023
1	PapainIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	MethyltransferasesIBA 01/2023
1	Pyridoxal KinaseIBA 01/2023
1	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 01/2023
1	Serine (L-Serine)FDA Link 01/2023
1	Serotonin (5 Hydroxytryptamine)IBA 01/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023
1	Vitamin B 6IBA 01/2023
1	Prokaryotic Initiation Factor-3IBA 01/2023
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 10/2022
1	Streptozocin (Streptozotocin)FDA Link 09/2022
1	Interleukin-17 (Interleukin 17)IBA 09/2022
1	Interleukin-6 (Interleukin 6)IBA 09/2022
1	Liposomes (Liposome)IBA 03/2022
1	SiliconIBA 03/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 01/2022
1	AntigensIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Thrombin FDA Link 01/2022
1	Antithyroid Agents (Antithyroid Drugs)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	antithrombin III-protease complexIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	bivalirudin (Angiomax)FDA Link 01/2022
1	OvalbuminIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Claudin-2IBA 12/2021
1	Broadly Neutralizing AntibodiesIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	astragaloside AIBA 10/2020
1	CytokinesIBA 10/2020
1	EpitopesIBA 01/2020
1	VaccinesIBA 01/2020
1	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2019
1	Poloxamer (Poloxamer 407)IBA 03/2019
1	AcidsIBA 06/2018
1	MicellesIBA 06/2018
1	alanyl-prolyl-arginyl-prolyl-glycineIBA 06/2018
1	monomethoxypolyethylene glycol (MPEG)IBA 06/2018
1	fosbretabulin (combretastatin A4)IBA 06/2018

Therapy/Procedure

6	Therapeutics 03/2023 - 01/2017
2	Immunotherapy 04/2023 - 02/2019
1	Intraperitoneal Injections 09/2022